Article Text

Download PDFPDF

European Stroke Organisation (ESO) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on acute management of basilar artery occlusion
    1. 1 Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland
    2. 2 Second Department of Neurology, ‘Attikon’ University Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece
    3. 3 Neuroradiology, Department of Diagnostic Imaging, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada
    4. 4 Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada
    5. 5 Department of Physiology, School of Medicine, University of Patras, Patras, Greece
    6. 6 School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
    7. 7 Department of Clinical Sciences Lund, Lund University, Skane University Hospital, Lund and Malmö, Sweden
    8. 8 Department of Neurology, Hôpital Gui de Chauliac, INSERM U1266, Montpellier, France
    9. 9 Neuroradiology, Inselspital, University of Bern, Bern, Switzerland
    10. 10 Clinic of Radiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia
    11. 11 European Stroke Organisation, Basel, Switzerland
    12. 12 UMC Hamburg-Eppendorf, Hamburg, Germany
    13. 13 Department of Clinical Neuroscience, Lausanne University Hospital and University of Lausanne, Bâtiment Hospitalier Principal, Lausanne, Switzerland
    14. 14 Department of Neurology, GHU Paris Psychiatrie et Neurosciences, INSERM U1266, Université Paris Cité, FHU NeuroVasc, Paris, France
    15. 15 Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands
    1. Correspondence to Dr Daniel Strbian; daniel.strbian{at}hus.fi

    Abstract

    The aim of the present European Stroke Organisation (ESO) guideline is to provide evidence-based recommendations on the acute management of patients with basilar artery occlusion (BAO). These guidelines were prepared following the Standard Operational Procedure of the ESO and according to the GRADE methodology.

    Although BAO accounts for only 1–2% of all strokes, it has very poor natural outcome. We identified 10 relevant clinical situations and formulated the corresponding Population Intervention Comparator Outcomes (PICO) questions, based on which a systematic literature search and review was performed. The working group consisted of 10 voting members (five representing ESO and five representing the European Society of Minimally Invasive Neurological Therapy (ESMINT)) and three non-voting junior members. The certainty of evidence was generally very low. In many PICOs, available data were scarce or lacking, hence, we provided expert consensus statements.

    First, we compared intravenous thrombolysis (IVT) to no IVT, but specific BAO-related data do not exist. Yet, historically, IVT was standard of care for BAO patients who were also included (although in small numbers) in IVT trials. Non-randomized studies of IVT-only cohorts showed a high proportion of favorable outcomes. Expert Consensus suggests using IVT up to 24 hours unless otherwise contraindicated. We further suggest IVT plus endovascular treatment (EVT) over direct EVT. EVT on top of best medical treatment (BMT) was compared with BMT alone within 6 and 6–24 hours from last seen well. In both time windows, we observed a different effect of treatment depending on a) the region where the patients were treated (Europe vs Asia), b) on the proportion of IVT in the BMT arm, and c) on the initial stroke severity. In case of high proportion of IVT in the BMT group and in patients with a National Institutes of Health Stroke Scale (NIHSS) score below 10, EVT plus BMT was not found better than BMT alone. Based on very low certainty of evidence, we suggest EVT+BMT over BMT alone (this is based on results of patients with at least 10 NIHSS points and a low proportion of IVT in BMT). For patients with an NIHSS score below 10, we found no evidence to recommend EVT over BMT. In fact, BMT was non-significantly better and safer than EVT. Furthermore, we found a stronger treatment effect of EVT+BMT over BMT alone in proximal and middle locations of BAO compared with distal location. While recommendations for patients without extensive early ischemic changes in the posterior fossa can, in general, follow those of other PICOs, we formulated an Expert Consensus Statement suggesting against reperfusion therapy in those with extensive bilateral and/or brainstem ischemic changes. Another Expert Consensus suggests reperfusion therapy regardless of collateral scores. Based on limited evidence, we suggest direct aspiration over stent retriever as the first-line strategy of mechanical thrombectomy. As an Expert Consensus, we suggest rescue percutaneous transluminal angioplasty and/or stenting after a failed EVT procedure. Finally, based on very low certainty of evidence, we suggest add-on antithrombotic treatment during EVT or within 24 hours after EVT in patients with no concomitant IVT and in whom EVT was complicated (defined as failed or imminent re-occlusion, or need for additional stenting or angioplasty).

    • Stroke
    • Thrombolysis
    https://creativecommons.org/licenses/by/4.0/

    This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • X @Fie0815

    • Presented at This contribution is being co-published in the following journals: European Stroke Journal and Journal of NeuroInterventional Surgery in 2024.

    • Contributors All authors except for Georgios Georgiopoulos, searched and screened the literature. Georgios Georgiopoulos, Daniel Strbian, and Georgios Tsivgoulis conducted the statistical analyses. Daniel Strbian wrote the first draft of the manuscript with help from the majority of the co-authors. All authors reviewed and edited the manuscript and approved the final version of the manuscript.

    • Funding Funding for the development of these guidelines (compensation for the methodologist’s work) was provided by the European Stroke Organisation, Basel, Switzerland. The author(s) did not receive financial support for the development, writing and/or publication of this guideline.

    • Competing interests All authors have completed a declaration of competing interests and details are available in online supplemental table 1.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.